Intelligence Platform
Patents
Browse 2,432 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 8765797
TG2 inhibitors and uses thereof
granted patentUS 8765751
Compounds useful as inhibitors of ATR kinase
granted patentUS 8759392
Amides as inhibitors of human secreted phospholipase A2
granted patentUS 8759389
Thiophene-carboxamides useful as inhibitors of protein kinases
granted patentUS 8759332
Hepatitis C virus inhibitors
granted patentUS 8759327
Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid
granted patentUS 8754080
Pyrimidine substituted purine compounds as kinase (S) inhibitors
granted patentUS 8754050
Macrocyclic compounds useful as inhibitors of histone deacetylases
granted patentUS 8754034
Structure-based design of peptide inhibitors of amyloid fibrillation
granted patentUS 8748607
Imidazopyrizine syk inhibitors
granted patentUS 8748601
Selective serine/threonine kinase inhibitors
granted patentUS 8742121
Process for the preparation of small molecule inhibitors of MDM2 and intermediates used th
granted patentUS 8741937
Gamma glutamyl transpeptidase inhibitors and methods of use
granted patentUS 8741912
Deazapurines useful as inhibitors of Janus kinases
granted patentUS 8741898
Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors
granted patentUS 8735593
Aminopyridines useful as inhibitors of protein kinases
granted patentUS 8735418
Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases
granted patentUS 8729119
Serotonin reuptake inhibitors
granted patentUS 8722895
Prolyl hydroxylase inhibitors and method of use
granted patentUS 8722889
Azaindoles useful as inhibitors of JAK and other protein kinases
granted patentUS 8722708
Substituted isoindolines as aspartyl protease inhibitors
granted patentUS 8716315
Analogs of thalidomide as potential angiogenesis inhibitors
granted patentUS 8716473
Substituted benzotriazines and quinoxalines as inhibitors of P7OS6 kinase
granted patentUS 8716301
Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to
granted